Research library

GHK-Cu Research Overview: Copper Coordination, Gene-Expression Findings and Dermatological Study Evidence

Compiled by:: Peptide Pilots Scientific Content Team
Reviewed by:: Peptide Pilots Quality & Compliance review
Last revised:: 3 September 2026

What is the published basis for GHK-Cu's activity, and how much of it comes from controlled human studies?

GHK is a tripeptide (glycyl-L-histidyl-L-lysine) that binds copper(II) with high affinity through its imidazole and amide nitrogens, forming the complex referred to as GHK-Cu. Published work reports effects on extracellular-matrix gene expression, including collagen and metalloproteinase regulation, in fibroblast culture, and a broad transcriptomic signature in cell lines. Human evidence is largely dermatological and cosmetic: small, often industry-linked studies of topical formulations reporting changes in skin appearance and biopsy measures. Systemic human data are absent.

This page is an educational literature summary for laboratory professionals. It is not medical advice, not a description of product performance, and it does not describe or endorse human or veterinary use. Materials referenced are supplied for controlled laboratory research only.

What is GHK-Cu?

GHK is a naturally occurring tripeptide found in human plasma, saliva and urine, whose plasma concentration is reported to decline with age. In the copper-bound form it functions as a copper(II) carrier and redox-active complex.

In laboratory work GHK-Cu is used in fibroblast and keratinocyte culture, matrix-remodelling assays, gene-expression profiling and topical formulation research. Copper content and complex stoichiometry are important experimental variables.

GHK-Cu names and identifiers

Also referred to as: copper tripeptide-1; Gly-His-Lys copper complex; GHK; glycyl-L-histidyl-L-lysine copper(II)

Peptide sequence	Gly-His-Lys (GHK)
Free peptide formula	C14H24N6O4, ≈340.4 g/mol
Copper complex formula	C14H22CuN6O4, ≈401.9 g/mol (1:1 Cu(II) complex)
CAS number (GHK-Cu)	89030-95-5
CAS number (free GHK)	49557-75-7
INCI designation	Copper tripeptide-1
Coordination	Square-planar Cu(II) coordination involving the histidine imidazole, the deprotonated amide nitrogen and the N-terminal amine

GHK-Cu research background

GHK was identified in the 1970s during work on plasma factors that altered the behaviour of cultured liver tissue from donors of different ages; the active fraction was traced to a copper-binding tripeptide.

Later work characterised the copper coordination chemistry and reported effects on fibroblast matrix synthesis, which led to sustained interest in dermatology and cosmetic science.

Since 2010 the literature has expanded into transcriptomic profiling, with reports that GHK modulates a large number of human genes in cultured cells. The research questions of interest are whether these transcriptomic signatures reflect specific signalling or general copper-dependent effects, and whether topical findings extend beyond skin.

Proposed GHK-Cu mechanisms and pathways

Evidence is separated by study type. In-vitro and animal findings describe model systems and do not establish equivalent behaviour in humans.

GHK-Cu in-vitro and cell-based evidence

Fibroblast cultures report increased collagen and glycosaminoglycan synthesis, and modulation of metalloproteinase and TIMP expression, consistent with matrix remodelling rather than simple accumulation.
Transcriptomic studies in cultured cells report modulation of a large fraction of the assayed transcriptome, including antioxidant and DNA-repair-associated gene sets. The specificity of such broad signatures is debated.
Copper delivery itself is a plausible contributor: copper is a cofactor for lysyl oxidase and superoxide dismutase, so some effects may reflect copper bioavailability rather than a peptide-specific receptor interaction.

GHK-Cu animal-model evidence

Rodent and rabbit wound models report faster closure and altered granulation-tissue composition with topical application.
Studies in diabetic and ischaemic wound models report increased angiogenic markers, though effect sizes vary between laboratories.

Published GHK-Cu human-study evidence

Topical dermatological studies report changes in skin density, wrinkle measures and biopsy-assessed collagen after multi-week application; most are small, and several are sponsored by formulators.
Comparative cosmetic studies have placed GHK-Cu alongside vitamin C and retinoic acid formulations, with mixed relative outcomes depending on endpoint and instrumentation.
No controlled human study of systemic administration has been published.

Published GHK-Cu studies

Selected published studies involving GHK-Cu
Study	Model / type	Research question	Main observation	Citation
Pickart & Margolina, GHK biological review	Review of in-vitro and animal data	What is the reported breadth of GHK-Cu activity?	Summarises matrix, antioxidant and gene-expression findings; the lead author is closely associated with commercial GHK development, which limits independence.	International Journal of Molecular Sciences, 2018
Maquart et al., matrix synthesis	Fibroblast culture and rat wound model	Does GHK-Cu alter extracellular-matrix synthesis?	Increased collagen and glycosaminoglycan accumulation in treated cultures and wound tissue.	FEBS Letters, 1993
Finkley et al., topical facial study	Human, 71 participants, 12 weeks, topical cream	Does a topical copper-peptide cream change skin measures versus placebo?	Reported improvement in wrinkle and skin-density measures versus vehicle in an industry-supported study.	Cosmeceuticals and Active Cosmetics (CRC Press), 2005
Copper coordination chemistry studies	Biophysical characterisation	How is copper(II) coordinated and how stable is the complex?	Defined the high-affinity 1:1 coordination geometry that underlies GHK's role as a copper carrier.	Indexed coordination-chemistry literature, 2020

Limitations of the GHK-Cu evidence

A substantial share of the influential secondary literature is authored by researchers with direct commercial ties to GHK products; independence should be checked before citing.
Broad transcriptomic effects reported in cell lines are difficult to interpret and have not been mapped to a defined receptor or single pathway.
Copper itself is biologically active, and few studies include an equimolar copper-only control, which weakens attribution of effects to the peptide complex specifically.
Human evidence is topical, short-duration and small-sample, with instrumentation-dependent endpoints; systemic human data do not exist.
Formulation variables (pH, chelators, stoichiometry, other actives) strongly affect complex stability, so cross-study comparison of topical results is unreliable.

GHK-Cu laboratory characteristics

Handling and analytical information reported in the literature and in supplier documentation. Values apply to laboratory materials and are not directions for any other use.

Appearance	Blue to deep-blue powder, the colour arising from the Cu(II) complex
Solubility	Water-soluble; complex stability is pH-dependent and reduced by competing chelators
Lyophilised storage	Commonly stored at −20 °C, desiccated and protected from light
Reconstituted handling	Prepared in copper-compatible buffers; strong chelators such as EDTA are avoided
Analytical testing	RP-HPLC purity and MS identity; copper content by ICP-MS or colourimetric assay where specified
Stability considerations	Copper dissociation at low pH and oxidation-sensitive histidine are the main documented concerns

Frequently asked GHK-Cu research questions

What does the Cu in GHK-Cu mean?

It denotes a coordinated copper(II) ion bound by the tripeptide in a 1:1 complex, involving the histidine imidazole, the deprotonated amide nitrogen and the N-terminal amine.

Is GHK naturally present in humans?

Yes. GHK has been detected in human plasma, saliva and urine, and published measurements report a decline in plasma concentration with increasing age.

Does GHK-Cu have a known receptor?

No specific high-affinity receptor has been established. Reported effects are attributed to matrix signalling and copper delivery, and specificity remains an open question.

Why does the powder appear blue?

The blue colour is characteristic of the Cu(II) coordination complex. A colourless preparation may indicate the free peptide rather than the copper complex.

GHK-Cu primary references

Pickart L, Margolina A (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19071987
Maquart FX, Pickart L, Laurent M, et al. (1993). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. https://doi.org/10.1016/0014-5793(88)80776-1
Finkley MB, Appa Y, Bhandarkar S (2005). Copper peptide and skin. Cosmeceuticals and Active Cosmetics (CRC Press). https://pubmed.ncbi.nlm.nih.gov/?term=copper+tripeptide+skin+clinical
Various (2020). Copper(II) coordination chemistry of glycyl-histidyl-lysine. Indexed coordination-chemistry literature. https://pubmed.ncbi.nlm.nih.gov/?term=GHK+copper+coordination

Authorship and revision

Compiled from primary literature and public databases. Every factual statement on this page is traceable to a listed reference. Compiled by Peptide Pilots Scientific Content Team; documentation and compliance review by Peptide Pilots Quality & Compliance review. First published 14 August 2026; last revised 3 September 2026. Pages are revised when the cited literature changes materially.

Catalogue reference

Peptide Pilots supplies GHK-Cu as a laboratory reagent with per-lot RP-HPLC and mass-spectrometry documentation. Quantities, testing, packaging and fulfilment details are on the catalogue page.

View GHK-Cu catalogue entry